HUTCHMED (HCM) Competitors $14.84 -0.43 (-2.82%) Closing price 04:00 PM EasternExtended Trading$14.84 +0.01 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM vs. QGEN, BBIO, MRNA, VRNA, ELAN, ROIV, RVMD, GRFS, RYTM, and LEGNShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include QIAGEN (QGEN), BridgeBio Pharma (BBIO), Moderna (MRNA), Verona Pharma PLC American Depositary Share (VRNA), Elanco Animal Health (ELAN), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Its Competitors QIAGEN BridgeBio Pharma Moderna Verona Pharma PLC American Depositary Share Elanco Animal Health Roivant Sciences Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech HUTCHMED (NASDAQ:HCM) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Does the media favor HCM or QGEN? In the previous week, QIAGEN had 19 more articles in the media than HUTCHMED. MarketBeat recorded 21 mentions for QIAGEN and 2 mentions for HUTCHMED. QIAGEN's average media sentiment score of 0.93 beat HUTCHMED's score of 0.00 indicating that QIAGEN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral QIAGEN 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HCM or QGEN more profitable? QIAGEN has a net margin of 18.30% compared to HUTCHMED's net margin of 0.00%. QIAGEN's return on equity of 14.77% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A QIAGEN 18.30%14.77%8.87% Which has stronger valuation & earnings, HCM or QGEN? QIAGEN has higher revenue and earnings than HUTCHMED. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$630.20M4.11$37.73MN/AN/AQIAGEN$1.98B5.28$83.59M$1.6927.81 Do institutionals & insiders hold more shares of HCM or QGEN? 8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 70.0% of QIAGEN shares are held by institutional investors. 3.6% of HUTCHMED shares are held by insiders. Comparatively, 9.0% of QIAGEN shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend HCM or QGEN? HUTCHMED presently has a consensus target price of $28.00, suggesting a potential upside of 88.68%. QIAGEN has a consensus target price of $49.69, suggesting a potential upside of 5.72%. Given HUTCHMED's stronger consensus rating and higher possible upside, equities analysts clearly believe HUTCHMED is more favorable than QIAGEN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00QIAGEN 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27 Which has more volatility & risk, HCM or QGEN? HUTCHMED has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. SummaryQIAGEN beats HUTCHMED on 12 of the 15 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.66B$3.13B$5.76B$9.85BDividend YieldN/A2.28%6.71%4.51%P/E RatioN/A7.5859.1122.53Price / Sales4.11458.96547.00119.09Price / Cash53.1644.5237.0558.92Price / Book3.359.9310.916.06Net Income$37.73M-$53.38M$3.29B$266.28M7 Day Performance0.07%0.05%0.01%-0.76%1 Month Performance-14.12%7.08%7.06%3.83%1 Year Performance-14.81%11.92%50.09%24.39% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED2.0509 of 5 stars$14.84-2.8%$28.00+88.7%-12.4%$2.66B$630.20M0.001,811QGENQIAGEN4.2785 of 5 stars$46.53+0.9%$49.69+6.8%+8.4%$10.34B$1.98B27.495,765Positive NewsBBIOBridgeBio Pharma4.1821 of 5 stars$51.76-1.5%$62.18+20.1%+80.4%$9.89B$221.90M-12.66400News CoveragePositive NewsAnalyst ForecastMRNAModerna4.4241 of 5 stars$24.09-1.6%$42.88+78.0%-67.0%$9.37B$3.24B-3.205,800VRNAVerona Pharma PLC American Depositary Share2.5979 of 5 stars$105.91+0.0%$109.00+2.9%+290.2%$9.16B$42.28M-106.9830News CoveragePositive NewsELANElanco Animal Health3.1154 of 5 stars$18.38-0.4%$17.33-5.7%+14.4%$9.12B$4.44B21.379,000Analyst RevisionHigh Trading VolumeROIVRoivant Sciences3.17 of 5 stars$11.93-0.1%$16.50+38.3%+7.0%$8.15B$29.05M-17.04860News CoveragePositive NewsAnalyst ForecastRVMDRevolution Medicines4.4891 of 5 stars$37.97-0.9%$69.92+84.2%-4.3%$7.10B$11.58M-8.44250Positive NewsInsider TradeGRFSGrifols3.9365 of 5 stars$9.97+1.0%$10.30+3.3%+2.2%$6.85B$7.81B8.5223,822Positive NewsGap UpRYTMRhythm Pharmaceuticals3.3217 of 5 stars$103.15-1.0%$101.57-1.5%+121.3%$6.85B$130.13M-34.27140News CoveragePositive NewsLEGNLegend Biotech3.532 of 5 stars$34.73+1.0%$74.22+113.7%-37.3%$6.41B$627.24M-39.472,609 Related Companies and Tools Related Companies QGEN Alternatives BBIO Alternatives MRNA Alternatives VRNA Alternatives ELAN Alternatives ROIV Alternatives RVMD Alternatives GRFS Alternatives RYTM Alternatives LEGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts